8.09.21
3 min. Read

Seven quiet health tech funding deals. Puzzle answer

Issue 036

Welcome back to E&O Mondays, the free newsletter from Exits & Outcomes that features health tech puzzles and trivia, new and under-the-radar funding news, paid content teasers and other digital health odds and ends.

 E&O Mondays.

In this issue:

  • Seven under-the-radar or not-yet-reported health tech funding deals.
  • The long-awaited answer to last week’s Health Tech Rebus Puzzle along with a few readers who got it right…
  • But wait: If this was forwarded your way, why not sign up as a paying subscriber to E&O by clicking right here…

 

Seven secret (or under-reported) health tech funding deals from the past week

Instead of rehashing the dozens of funding deals you’ve already read elsewhere, I focused this week on a number of deals that you likely have not yet read about. (These are all first in E&O — as far as I can Google.)

* Please note: These rounds are unannounced so the full amount the company raises as part of its current round may be higher than the numbers below.

  • $17.7 million – Homecare [DOT] com – “HomeCare [DOT] com provides technology and tools to help families and Caregivers connect with each other.” Site
  • $8.7 million – Asimily – This company offers connected medical device management software to health systems. Site
  • $5.3 million – Reimagine Care – This one is tough to cut through, but to give you a vague sense of what they do: Reimagine “provides technology-enabled services to support community oncologists and healthcare systems in delivering high-quality, more affordable, patient-centric cancer care.” And the company aims “to become the leading national network for the delivery of value-based oncology care” Site
  • $4 million – Courier Health – This news isn’t just stealthy the whole company is still mostly quiet. (For example, the two founders both list themselves at a stealth startup on LinkedIn instead of naming Courier.) The website has a few more hints about the product offerings than the company’s tagline: “The next generation of Patient Engagement for Life Sciences.” Site
  • $1.8 million in debt and other options – Hygieia – This company offers a diabetes app called d-Nav. “The d-Nav Program was created to improve and simplify insulin treatment to make a difference and help more people who are on insulin therapy succeed. The d-Nav program uses an FDA-cleared app to identify glucose patterns and automatically recommend an insulin dose each time the patient injects.” Site
  • $570,000 in equity, options, and other securities – YUR Fitness – “Fitness tracking across any virtual reality game… YUR uses machine learning to analyze movement from both controllers and headsets as well as your biometric profile to give you tailor-made fitness metrics. YUR keeps the notion of a workout alive while you are within any game and it is running in the background. A workout can temporarily be saved offline and will later be uploaded to our servers if you, for example, want to use VR tracked by YUR offline.” Site
  • $100,000 added to its now $2.25 million raise – BetterYou – This isn’t the first time BetterYou has added another $100,000 to this round. “BetterYou is an AI companion that helps you achieve your goals. To date, we’ve helped thousands of people get an extra 30 minutes of sleep each night, improve their talk time with friends by 10 minutes each day, or get another workout in every week.” Site

Health Tech Rebus Answer

Here are four (of the many) very quick-witted E&O readers who sent in the correct answer to last week’s Rebus puzzle:

  • Ushma Baros, NHS Partnerships, Big Health
  • Dena Mendelsohn, Head of Compliance and Privacy, HumanFirst
  • Lisa Suennen, Lead, Digital & Technology business and Lead, Manatt Ventures (Find her on LinkedIn here)
  • Robert Loudon, Associate Director Market Research, Optum

The answer to last week’s puzzle: “For entertainment purposes only”

In the early years of mobile medical apps, this was a commonly used caveat in app store descriptions. App makers were unsure of which apps crossed the line into FDA’s regulatory purview, so they described their blood pressure management apps as “for entertainment purposes only”. These thrilling events led many digital health keynoters to describe digital health as “The Wild West”.

ICYMI — Last week’s Rebus puzzle is below.

Here’s how to play: This kind of puzzle is called a Rebus. Write down or think of the word for what’s pictured in each box as a starting point. Then swap letters (if you see =), or remove letters (when you see -), or add letters (when you see +) at the beginning, middle, or end of the words as noted. Then sound it out.

Hint: When a mobile medical app includes this disclaimer in its AppStore description, scroll on…

That’s a wrap on E&O Mondays 036.
article end logo
×
Spring Health’s new biz. Coca-Cola’s benefits.
2.02.24
8 min. Read
Facebook’s RCT for AI bot Zenny. More trials
1.26.24
7 min. Read
Which virtual clinics got FTC-OCR letters?
1.19.24
6 min. Read
Digging into the Omada-Amazon marketing deal.
1.12.24
9 min. Read
FDA de novo for Google smartphone thermometer.
1.05.24
6 min. Read
New state launches for Midi Health, HeyJane, Swing Care and more
12.21.23
6 min. Read
PDT-to-virtual-clinic trend continues. HCPCS tweaks.
12.15.23
8 min. Read
Teladoc customer wins. Pricing database updates
12.08.23
5 min. Read
Mahana Tinnitus. New CPT hopefuls. Better cuts salaries
12.01.23
6 min. Read
UnitedHealth’s employee benefits. Omada signals IPO. Detailed Spring Health pricing.
11.21.23
9 min. Read
  • First
  • Previous
  • 1 of 35
  • Next
  • Last